Basel Medical Group Addresses Nasdaq Minimum Bid Price Requirement
Compliance With Nasdaq Periodic Filing Requirement
Basel Medical Group Addresses Nasdaq Minimum Bid Price Requirement
Compliance With Nasdaq Periodic Filing Requirement
Initial Insider Holdings Report
Singapore – Mar 4, 2026 – Basel Medical Group Ltd
Basel Medical Group Ltd (NASDAQ: BMGL)
Basel Medical Group Ltd director Paul D. Freudenthaler filed an initial ownership report on Form 3. This filing identifies him as a director of the company but does not list any specific share transactions or changes in ownership. It serves as a baseline disclosure of his status as an insider.
